|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 901 to 915 out of 915 for Nf1

<< First    < Previous  |  Next >    Last >>
0.019s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Publication  
First Author: Voigt E
Year: 2023
Journal: Int J Mol Sci
Title: FOXM1, MEK, and CDK4/6: New Targets for Malignant Peripheral Nerve Sheath Tumor Therapy.
Volume: 24
Issue: 17
Publication
First Author: Brockman QR
Year: 2023
Journal: Sci Rep
Title: Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models.
Volume: 13
Issue: 1
Pages: 14798
Publication  
First Author: White EE
Year: 2024
Journal: Cancers (Basel)
Title: The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation.
Volume: 16
Issue: 5
Publication
First Author: Shaughnessy JD Jr
Year: 1999
Journal: Oncogene
Title: Mrvi1, a common MRV integration site in BXH2 myeloid leukemias, encodes a protein with homology to a lymphoid-restricted membrane protein Jaw1.
Volume: 18
Issue: 12
Pages: 2069-84
Publication
First Author: Zhang P
Year: 2013
Journal: PLoS One
Title: DDAH1 deficiency attenuates endothelial cell cycle progression and angiogenesis.
Volume: 8
Issue: 11
Pages: e79444
Publication
First Author: McCool KW
Year: 2020
Journal: Cancer Res
Title: Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
Volume: 80
Issue: 4
Pages: 877-889
Publication
First Author: Ethelberg S
Year: 1997
Journal: J Virol
Title: Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Volume: 71
Issue: 10
Pages: 7273-80
Publication
First Author: Tischler AS
Year: 1995
Journal: Endocr Pathol
Title: Characterization of Pheochromocytomas in a Mouse Strain with a Targeted Disruptive Mutation of the Neurofibromatosis Gene Nf1.
Volume: 6
Issue: 4
Pages: 323-335
Publication
First Author: Rice JM
Year: 2004
Journal: Toxicol Appl Pharmacol
Title: Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models.
Volume: 199
Issue: 2
Pages: 175-91
Publication
First Author: Fisher MJ
Year: 2021
Journal: Nat Med
Title: Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.
Volume: 27
Issue: 1
Pages: 165-173
Publication
First Author: Dougherty J
Year: 2023
Journal: PLoS One
Title: Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.
Volume: 18
Issue: 2
Pages: e0277305
Publication  
First Author: Hernandez DP
Year: 2024
Journal: Cancers (Basel)
Title: Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation.
Volume: 16
Issue: 3
Publication
First Author: Baba H
Year: 1995
Journal: J Neurosci Res
Title: GapIII, a new brain-enriched member of the GTPase-activating protein family.
Volume: 41
Issue: 6
Pages: 846-58
Publication
First Author: Stauffer DR
Year: 1998
Journal: J Biol Chem
Title: Characterization of transcriptional regulatory elements in the promoter region of the murine blood coagulation factor VII gene.
Volume: 273
Issue: 4
Pages: 2277-87
Publication  
First Author: Sabetghadam A
Year: 2020
Journal: Exp Neurol
Title: Increased epileptogenicity in a mouse model of neurofibromatosis type 1.
Volume: 331
Pages: 113373